Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H.-Y. Min
Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-Like Growth Factor I Receptor Monoclonal Antibody
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Molecular Predictors of Response to a Humanized Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody in Breast and Colorectal Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
RAV12 Accelerates the Desensitization of Akt/PKB Pathway of Insulin-Like Growth Factor I Receptor Signaling in COLO205
Cancer Research
Cancer Research
Oncology
R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis
PLoS ONE
Multidisciplinary
Insulin-Like Growth Factor-I-Induced DNA Synthesis in Insulin-Secreting Cell Line RINm5F Is Associated With Phosphorylation of the Insulin-Like Growth Factor-I Receptor and the Insulin Receptor Substrate-2
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes
Regulation of Survival Signals From the Insulin-Like Growth Factor-I Receptor
Biochemical Society Transactions
Biochemistry
Insulin-Like Growth Factor 1 Receptor Antibody Induces Rhabdomyosarcoma Cell Death via a Process Involving AKT and BCL-xL
Oncogene
Cancer Research
Genetics
Molecular Biology
The Three Dimensional Structure of the Type I Insulin-Like Growth Factor Receptor
Molecular Pathology
Phase I Study of the Anti Insulin-Like Growth Factor 1 Receptor (IGF-1R) Monoclonal Antibody, AVE1642, as Single Agent and in Combination With Bortezomib in Patients With Relapsed Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
